Zaloguj się

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the enzyme-catalyzed conversion of acetaldehyde to ethanol by aldehyde dehydrogenase or the transformation of acetophenone to phenylethanol, signifying the reduction of ketones.

Reductive reactions also target alcohols and carbon-carbon double bonds. The enzyme alcohol dehydrogenase oxidizes alcohols to aldehydes or ketones, as exemplified by the conversion of retinol to retinaldehyde. Carbon-carbon double bonds can be diminished to single bonds through enzymes like cytochrome P450 reductase, as seen in the reduction of fumarate to succinate.

Reduction reactions extend to N-compounds such as nitro, azo, and N-oxide. Nitroreductases, for instance, reduce nitro groups to amino groups, as demonstrated by the conversion of nitrofurantoin to its amine form. Miscellaneous reductive reactions cover the reduction of diverse functional groups. For example, azoreductases reduce azo compounds to primary amines, as in the transformation of sulfasalazine to mesalamine and sulfapyridine.

Reductive reactions in phase I biotransformation contribute significantly to drug detoxification and are instrumental in drug elimination from the body.

Z rozdziału 5:

article

Now Playing

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

147 Wyświetleń

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

101 Wyświetleń

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

201 Wyświetleń

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

99 Wyświetleń

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

43 Wyświetleń

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

37 Wyświetleń

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

72 Wyświetleń

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

97 Wyświetleń

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

82 Wyświetleń

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

71 Wyświetleń

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

88 Wyświetleń

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

59 Wyświetleń

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

23 Wyświetleń

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

92 Wyświetleń

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

63 Wyświetleń

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone